Patient Centricity and Advocacy

　　Biopharma and device manufacturers are taking great measures to include the voice of the patient in all aspects of the drug development process – from pre-clinical to commercial. While being truly patient centric requires an organization-wide commitment and patient focused employees in every department, strong partnerships with advocacy groups serve as a solid foundation for this paradigm shift. This summit brings together manufacturer and advocacy professionals to discuss how to most effectively engage the patient in drug development and communication strategies, what areas are the most ripe for collaboration, and to share strategies and results from successful case examples.

Topics to be Addressed: Address Strategies for Overcoming Roadblocks in Partnerships with Advocacy and Industry Ensure Patient Access to Treatment—The Intersection of Patient Assistance and Advocacy Groups Understand Patients as People by Collaborating and Partnering with Physician Groups and Integrated Health Care Systems Making Social Part of the Mix—Bringing the Traditional Relationship to the Digital Forum The Role of the e-Patient Champion—Innovative Strategies for Change Gain insights on How

the FDA is Using Patient Insights in PDUFA Meetings and Plans to Incorporate Industry into That Conversation Create More Efficient and Effective Clinical Trials through Advocacy Partnerships Case Study: Best Practices for effective Engagement with Patient Groups Around Clinical Trials Case Study: Real World Takeaway Strategies for Successful Partnerships Collaborate with Advocacy Organizations to Measure Value in Joint Programs and Initiatives US Advocacy Groups are Going Global— Understand Partnership Opportunities, Challenges, and Principles for Interaction